Company
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| ADX-629 (Open-label) | Phase 2 | Atopic Dermatitis |
Latest
Follow Aldeyra Therapeutics, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.